Business
Capping THC Levels Is A Bad Idea – Cannasplaining the New Marijuana Industry to Peg O’Connor
Allow me to “cannasplain” why Peg OConnor has it wrong about cannabis Potency
It seems that every other week I’m here needing to cannasplain to people who have no idea about cannabis, potency, or any subjective experience with any real drug usage. Today, Peg O’Connor wrote an opinion piece in USA Today which was titled, Not your grandma’s weed: Why potency limits must be part of any push to legalize cannabis.
As one would expect, this article is riddled with assumptions, erroneous data, and faulty conclusions. It is my duty as a defendant of sanity to dismantle this hit piece by Peg and teach her the errors of her ways.
Let’s jump into it!
The Three Assumptions
Peg starts off by telling us how cannabis has transformed in the public eye and claims that “no drug” had undergone such a transformation. But I’d like to point out that “alcohol” is a drug that had undergone such a transformation not even a hundred years earlier.
There was a time when alcohol was illegal in the United States mainly due to a puritanical movement spearheaded by women – but once prohibition stepped in and regulations went out the door – bootleg liquor became a dangerous thing. In fact, it because so dangerous that it was women who fought to legalize alcohol again. In many cases, the same women who fought to prohibit it years earlier!
Therefore, right off the bat we know that Peg’s knowledge of drug history is probably weak and that she’d be drawing all her data from official sources.
Nonetheless, she argues that there are three main reasons why legalization has happened at such a scale.
- Based on anecdotal evidence with moving testimony by patients and their families, state legislators became convinced of marijuana’s salutary effects. The federal government had instituted a near-categorical prohibition on marijuana research, so the absence of studies helped the case for medical marijuana because of limited evidence about whether it was harmful.
- Marijuana has enjoyed a reputation of being harmless. Many assume that marijuana is not addictive like drugs that have been culturally and morally coded as “bad” or “dangerous,” such as heroin or methamphetamine.
- Many recognize that the Controlled Substances Act and its enforcement through the war on drugs were conceived and implemented in racialized and racist ways. There’s no denying the fact that Black Americans have been disproportionately arrested, charged, convicted and sentenced for drug crimes. – SOURCE
According to Peg, these were the only reasons why or at the very least, the “main reasons” why people wanted to opt out of cannabis prohibition.
Before we continue, allow me to clarify.
- There are and were MORE than anecdotal evidence to support cannabis legalization. In fact, while most of the studies on cannabis was commissioned to find its “negative effects”, that research also revealed plenty of medical bonuses. For example, we’ve known that cannabinoids had anti-cancer properties for many decades now. We also knew that cannabis helped stimulate the appetite of patients who were going through chemo. We also knew from studies that it helped against Wasting Syndrome, a side effect from HIV/AIDS. The fact of the matter is that there were many studies that illustrated the medical benefits of cannabis despite the obvious attempt to smear it with scientific literature.
- Marijuana is “LESS HARFMFUL” than the vast majority of legal drugs on the market. This is the argument, not that it’s “harmless”. Hell, even drinking water in excess isn’t “harmless”, so why would one think that cannabis is the exception. It’s certainly NOT as addictive as heroin or meth and has a far lower physical effect on the users. For example, one can abuse an ounce of cannabis per day for the next 80 years and have minimal physical side effects compared to abusing a bottle of Jack Daniels daily. You’d probably not make it past 50-years old in the latter. Once again, this is an assumption from the prohibition camp – not cannabis users.
- I agree, the CSA is racist, but more importantly, it is a document that gave the pharmaceutical community a monopoly over all the drugs on the planet and then gave them the police to be their enforcers. They are essentially “legal drug lords” and the state is its “arm of enforcement” which all was dreamt up by Nixon in the 1970s.
Now that we have cleared the three assumptions, we see what Peg has to say about legalization;
I am in favor of the provisions that would establish a trust fund for communities impacted by the war on drugs and an expungement process for individuals with marijuana convictions. I have deep reservations, however, about the push to decriminalize cannabis without restrictions on the potency of the products.
Obviously, within a regulated market there would be certain “norms” to follow, however to restrict potency on cannabis would do nothing to stop the flow of high potency cannabis. The past 80-years of prohibition has taught us as much. Therefore, creating a trust fund (social justice) does nothing to undo the damage of the drug war. Only by removing those laws do you decentralize the power and remove the enforcement wing of the pharmaceutical industry to go after brown-skinned people.
Making comparisons with the tobacco industry
Something that I hear a lot from prohibitionists is that they compare cannabis to tobacco. While both are plants, the process of each crop is widely different. Tobacco gets sprayed with fertilizers and contain more than 7000 chemicals with 69 of them known to be causing cancer.
Cannabis on the other hand, have strict limits on the type fertilizers used and while burning any plant material does generate carcinogens, the cannabinoids in cannabis essentially “deactivates” the receptors in the body of these carcinogens. It’s why there are not many cases of lung cancer with cannabis smokers.
This could be the potential reason;
Smoke from tobacco and cannabis contains many of the same carcinogens and tumor promoters [20,21]. However, cannabis and tobacco have additional pharmacological activities, both receptor-dependent and independent, that result in different biological endpoints. Polycyclic aromatic hydrocarbons found in smoke are pro-carcinogens that are converted to carcinogens by the enzymatic activity of the cytochrome P4501A1 oxidase protein (CYP1A1 gene product). Benzo [a] pyrene is converted to its carcinogenic metabolite diol epoxide, which binds to specific hyper-mutable nucleotide sequences in the K-ras oncogene and p53 tumor suppressor [22]. Recent work by Roth et al. demonstrates that THC treatment of murine hepatoma cells caused a dose dependent increase in CYP1A1 gene transcription, while at the same time directly inhibiting the enzymatic activity of the gene product [23]. Thus, despite potentially higher levels of polycyclic aromatic hydrocarbons found in cannabis smoke compared to tobacco smoke (dependent on what part of the plant is smoked), the THC present in cannabis smoke should exert a protective effect against pro-carcinogens that require activation. In contrast, nicotine activates some CYP1A1 activities, thus potentially increasing the carcinogenic effects of tobacco smoke [24]. – Source
Of course, there is still a lot about cannabis and cannabinoids we don’t know – however comparing cannabis to tobacco is not an “Apples to Apples” comparison. They are wildly different drugs and commercial tobacco is different than natural tobacco mainly due to the industrial pesticides – some of which are radioactive!
There is a possibility of “Commercial Cannabis” going that route, especially with Wall Street Cannabis enterprises who like to maximize profits at the expense of everyone and everything else – but within the context of “home grown” or “locally sourced” cannabis, this would not be the case.
Why Capping the Potency of Cannabis is a dumb idea!
In the conclusion of Peg’s opinion piece there is a call for legislators to cap cannabis potency.
We still do not know the risks of marijuana, though physicians are starting to get a much clearer picture. Chronic vomiting, psychosis, addiction, and increased anxiety and depression follow from the regular use of high-potency marijuana in teenagers.
Legislators on the state and federal levels have an opportunity to make better laws about marijuana than they ever had with tobacco products. They need to cap the potency of pot.
While there are potential risks for SOME people when it comes to smoking cannabis, the vast majority of users will have no problem. They won’t have an issue with addiction, they won’t start chronically vomiting, they won’t have psychosis (other than temporary induced psychosis aka being high), and in fact, would reduce their depression and anxiety.
I highlighted a keyword in the conclusion, “Teenagers”. This is the classic “Won’t anyone think about the children argument!” This argument believes that by “capping the freedoms of adults, we can deter children from consuming” which is an idiotic idea.
If this was true, then the outright prohibition of cannabis should have completely stopped kids from smoking weed…except, it didn’t, and in fact possibly more kids started doing other drugs as a result from prohibition since the illicit market cares not for what you buy, as long as you buy it.
Secondly, by capping cannabis in your state, you make high-potency products a highly sought after commodity that now has an inflated value due to the artificial scarcity created by the regulations. All this means is that now, instead of having high-potency products in stores that are 100% compliant with marijuana laws – you’ll instead put them in the hands of illicit vendors who don’t pay tax and can mark up the product significantly more.
Since they are vape cartridges, you can store more of it while taking up less space. Every other market that has higher potency products, will now have people incentivized to purchase these products in other markets, drive a few hours, and sell them at a higher price in an unregulated manner.
If we’re talking about “smart ideas” – capping cannabis ain’t one of them.
The ACTUAL solution
In order to find the solution you need to first identify the problem. Unfortunately, Peg only managed to identify a “symptom” of the problem but failed to see the root of the problem.
And what is the root of the problem?
Simple – drug education!
Since the 70s, governments around the world have been banging on the “DON’T DO DRUGS!” while subsidizing the pharmaceutical industry that drugged you and your kids for record profits. Instead of suggesting physical activity, the pharmaceutical industry incentivized physicians to prescribe you Ritalin (a related drug to methamphetamines), they gave you opioids to treat sprained ankles, etc.
More people die each year from the pharmaceutical industry than all illicit drug overdoses combined.
The problem isn’t “putting a cap” on anything. It’s about growing up and becoming mature about our drug use. To recognize that it’s a fundamental part of the human experience and that with the proper set and setting, you can enjoy drugs and have immense benefit in your life.
What Peg is actually suggesting is to “transform prohibition”, to “modify it, yet remains faithful as a prohibitionist.
But then again, her PhD is related to “philosophy and gender, women and sexuality studies at Gustavus Adolphus College in St. Peter, Minnesota.”
In other words, she knows absolutely nothing about cannabis, cannabis laws, cannabis policy, the user experience etc. Yet for some reason, she was merited an opinion piece in USA Today.
This is why you know this is just propaganda.
Business
Jio’s 1,600-Satellite LEO Constellation Gets Technical Green Light
Reliance Jio has crossed a significant milestone in its space connectivity ambitions after its proposal to deploy a Low Earth Orbit (LEO) satellite constellation of around 1,600 satellites received a positive technical assessment from the Indian National Space Promotion and Authorisation Centre (IN-SPACe).
The evaluation, conducted jointly by IN-SPACe, the Indian Space Research Organisation (ISRO), and the Wireless Planning and Coordination (WPC) wing of the Department of Telecommunications, reportedly concluded that Jio’s proposed system meets the required technical standards and is comparable to leading global satellite broadband networks.
India’s Indigenous LEO Satellite Vision
Under the proposal, Reliance Jio plans to deploy between 1,600 and 1,650 satellites in Low Earth Orbit at an altitude of around 650 kilometres.
The planned constellation is expected to provide high-speed satellite connectivity across India, with approximately 32 satellites visible from any location at a given time. The company aims to roll out the network within the next two to three years, subject to regulatory approvals.
According to industry estimates, the satellite system could deliver 4.5 to 5 terabits per second (Tbps) of total data capacity, making it one of the largest satellite broadband projects proposed in India.
The project is expected to require an investment of $10–15 billion (approximately ₹95,000 crore to ₹1.42 lakh crore), reflecting the scale of infrastructure needed for satellite manufacturing, launches, ground stations, and user terminals.
Regulatory Process Moves Forward
Following the successful technical review, the proposal is expected to move into the next phase of regulatory approvals.
The government may now assist Jio in securing orbital slots, coordinating spectrum usage, and filing applications with the International Telecommunication Union (ITU), the global body responsible for managing satellite orbit and frequency allocations.
Obtaining orbital rights remains a critical step, as Low Earth Orbit has become increasingly competitive due to the growing number of satellite broadband projects being planned worldwide.
Officials also indicated that the proposed satellite architecture has been designed to coexist with future Indian LEO constellations, allowing multiple domestic operators to share orbital resources efficiently.
Broadband, Mobile Connectivity, and Strategic Applications
Jio plans to use the satellite network to provide a range of communication services, including satellite broadband, mobile backhaul, enterprise connectivity, and direct-to-device (D2D) satellite communication, particularly in remote and underserved regions where conventional telecom infrastructure is limited.
The company also intends to establish 20 to 22 ground stations across India to support network operations.
Apart from commercial telecommunications, officials have highlighted the project’s potential strategic importance. A domestically developed satellite constellation could strengthen India’s communication infrastructure, reduce dependence on foreign satellite operators, and support national security requirements.
Reports suggest preliminary discussions are underway regarding the possibility of integrating defence-related payloads into some satellites, enabling both civilian and strategic use.
Major Step for India’s Space and Telecom Sectors
Industry analysts view the technical clearance as an important milestone in India’s expanding private space ecosystem. If Jio secures the remaining regulatory approvals and international orbital clearances, the project could become the country’s first large-scale indigenous LEO satellite broadband network.
The initiative also aligns with India’s broader efforts to expand digital connectivity while strengthening its presence in the global satellite communications market.
Business
Alleged Crores Pharma Scam Mastermind Arrested from Surat
After evading law enforcement for nearly 13 years, an accused linked to a large-scale pharmaceutical fraud case has been arrested by Delhi Police from Surat, Gujarat. The suspect is alleged to have orchestrated a series of financial scams involving fake identities, forged documents, and dishonoured cheques used to procure high-value pharmaceutical raw materials.
Authorities say the accused, identified as Himmat Singh Lodha, is believed to have defrauded multiple pharmaceutical companies in Delhi of goods worth approximately ₹98 lakh before disappearing and remaining underground for years.
Fake Business Deals and Dishonoured Cheques Used in Fraud
Investigators claim the accused posed as a legitimate pharmaceutical trader and placed bulk orders for expensive drug ingredients, offering post-dated cheques as payment security.
In one documented case from 2013, he allegedly obtained around 550 kilograms of Gliclazide, a diabetes-related pharmaceutical ingredient, valued at over ₹26 lakh. When suppliers attempted to encash the cheques, they were reportedly returned with the remark “account closed.”
Following the transaction, the accused allegedly vacated his office and rented residence and disappeared without settling payments. He was later declared a proclaimed offender in 2016 after repeatedly failing to appear before court proceedings. Authorities had also issued a reward for information leading to his arrest.
Multiple Identities and Repeated Fraud Pattern
Police investigations further link the accused to another cheating case dating back to 2012, where he allegedly used a fake identity, “Kailash Jain,” to obtain a large consignment of Ambroxol HCL, a pharmaceutical compound used in cough medications. The value of that consignment was estimated at around ₹72 lakh.
Officials believe the accused followed a consistent modus operandi—posing as a credible businessman, securing high-value goods on deferred payment terms, and then disappearing after delivery while shutting down business operations.
Investigators suspect that forged business records, fake company credentials, and fabricated financial histories were used to build trust with suppliers and gain access to expensive raw materials.
Multi-State Surveillance Leads to Arrest in Surat
A special Crime Branch team tracked the accused through coordinated surveillance efforts across multiple cities, including Mumbai, Ahmedabad, and Surat. After nearly a month of technical monitoring and intelligence gathering, officials located and arrested him from a residential area in Surat.
Authorities also revealed that the accused had been involved in property-related activities while staying under the radar to avoid detection.
Growing Threat of Corporate Identity Fraud
The case highlights a rising trend of organised financial fraud targeting industries that rely heavily on trust-based transactions and deferred payments. Experts note that criminals increasingly exploit gaps in corporate verification systems by using fake GST registrations, temporary offices, and forged documentation to appear legitimate.
Cybercrime and financial fraud specialists warn that such schemes are becoming more complex with the widespread availability of digital business tools, making it easier to create convincing but fraudulent corporate identities.
Experts Urge Stronger Due Diligence in High-Value Transactions
Experts, including former IPS officer and cybercrime specialist Prof. Triveni Singh, emphasize the need for stricter verification procedures in commercial dealings. He noted that relying solely on paperwork or digital business profiles can expose companies to significant financial risk.
Authorities and industry experts recommend physical verification of business operations, bank account validation, and detailed background checks before engaging in high-value or deferred-payment transactions—particularly in sectors like pharmaceuticals, where single consignments can involve transactions worth crores.
Business
EU Pressure Builds on Google as Regulators Face Calls for Massive Fine Over Search Practices
A growing coalition of European industry groups is intensifying pressure on regulators to take decisive action against Google over allegations of unfair search practices that could reshape competition rules across the region’s digital economy.
Investigation Under Digital Markets Act Gains Momentum
The case is being examined by the European Commission under the European Union’s landmark Digital Markets Act (DMA), introduced to curb the dominance of major technology platforms and ensure fair competition.
Launched in March 2024, the investigation focuses on whether Google has been prioritising its own services in search results, potentially disadvantaging rival businesses that rely on online visibility to reach customers.
Industry Groups Demand Swift Action
Several prominent European organizations have jointly urged regulators to conclude the probe without further delay. They argue that prolonged investigations allow alleged anti-competitive practices to continue, putting European companies—especially startups—at a disadvantage.
Signatories include the European Publishers Council, the European Magazine Media Association, the European Tech Alliance, and EU Travel Tech.
In a joint statement, these groups warned that delays in enforcement are affecting innovation, profitability, and growth prospects for regional businesses competing in digital markets.
Google Denies Allegations
Google has rejected claims of bias, stating that its search algorithms are designed to deliver the most relevant and useful results to users. The company has also proposed adjustments to address regulatory concerns.
However, critics argue that these changes are insufficient and fail to address the core issue of market dominance.
Potential Billion-Euro Penalties
If found in violation of the DMA, Google could face significant financial penalties. Under EU rules, fines can reach a substantial percentage of a company’s global turnover, potentially amounting to billions of euros.
Regulators may also impose corrective measures requiring changes to business practices, which could have long-term implications for how digital platforms operate in Europe.
Wider Implications for Big Tech
The case highlights ongoing tensions between European regulators and major U.S. technology firms. In recent years, the EU has taken a more aggressive stance in enforcing competition laws, aiming to create a level playing field for local businesses.
A final ruling against Google could set a major precedent, influencing future enforcement actions and shaping the regulatory landscape for global tech companies operating within Europe.
As scrutiny intensifies, the outcome of the investigation is expected to play a critical role in defining the future of digital competition across the European Union.
-
Business3 years agoPot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business3 years agoNew Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business3 years agoAlabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business3 years agoWashington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business3 years agoMarijuana companies suing US attorney general in federal prohibition challenge
-
Business3 years agoLegal Marijuana Handed A Nothing Burger From NY State
-
Business3 years agoCan Cannabis Help Seasonal Depression
-
Blogs3 years agoCannabis Art Is Flourishing On Etsy
